AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33999544 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention (tailored, progressive rehabilitation including strength, balance, mobility, and endurance), initiated during or early after hospitalization and continued for 36 outpatient sessions.
Number of subjects: 349
Study 33999544 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 349
Study 33999544 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention (tailored, progressive rehabilitation)
Number of subjects: 349
Study 32597700 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP-SD)
Number of subjects: 25
Study 34772324 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar (glucose) solution
Number of subjects: 61
Study 34772324 — intervention group
Group type: COMPARATOR
Intervention: Non-nutritive sweetener (aspartame) solution
Number of subjects: 61
Study 33704185 — intervention group
Group type: EXPERIMENTAL
Intervention: Alloderm-RTU
Number of subjects: 62
Study 33704185 — intervention group
Group type: COMPARATOR
Intervention: DermACELL
Number of subjects: 62
Study 34029328 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure (PE) therapy, provided within 72 hours after a traumatic event, consisting of three sessions.
Number of subjects: 32
Study 34029328 — intervention group
Group type: COMPARATOR
Intervention: Non-directive support (control group).
Number of subjects: 32
Study 34543068 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise training for 1 year (n=30)
Number of subjects: 46
Study 34543068 — intervention group
Group type: COMPARATOR
Intervention: Attention control for 1 year (n=16)
Number of subjects: 46
Study 35177254 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic approach
Number of subjects: 190
Study 35177254 — intervention group
Group type: COMPARATOR
Intervention: Microscopic technique
Number of subjects: 190
Study 33852723 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted circulating IGF-1
Number of subjects: 2069
Study 33852723 — intervention group
Group type: COMPARATOR
Intervention: High GRS of IGF-1
Number of subjects: 2069
Study 33852723 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted circulating IGFBP-3
Number of subjects: 2069
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Previous recreational PA of 0 MET-hours/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Previous recreational PA of 0.1-9.9 MET-hours/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Previous recreational PA of 20-29.9 MET-hours/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Previous recreational PA of 30-39.9 MET-hours/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Previous recreational PA of ≥40 MET-hours/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Mentally active SB of 7-14.9 h/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Mentally active SB of 15-20.9 h/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Mentally active SB of ≥21 h/week
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Passive SB of 3-3.9 h/day
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Passive SB of 4-4.9 h/day
Number of subjects: 3228
Study 33150410 — intervention group
Group type: COMPARATOR
Intervention: Passive SB of ≥5 h/day
Number of subjects: 3228
Study 33402037 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 75
Study 33402037 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 75
Study 33402037 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation (usually apixaban)
Number of subjects: 75
Study 33402037 — intervention group
Group type: EXPERIMENTAL
Intervention: Any antithrombotic therapy
Number of subjects: 75
Study 35475921 — intervention group
Group type: EXPERIMENTAL
Intervention: External pneumatic compression (EPC) treatment (110 mmHg)
Number of subjects: 30
Study 35475921 — intervention group
Group type: EXPERIMENTAL
Intervention: Static compression (SC) garment (20-30 mmHg)
Number of subjects: 30
Study 35475921 — intervention group
Group type: COMPARATOR
Intervention: No treatment control (CTL)
Number of subjects: 30
Study 33246873 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized self‐management combined with physical therapy
Number of subjects: 53
Study 33246873 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy intervention
Number of subjects: 53
Study 35133617 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-05280014
Number of subjects: 707
Study 35133617 — intervention group
Group type: COMPARATOR
Intervention: trastuzumab-EU
Number of subjects: 707
Study 32891506 — intervention group
Group type: COMPARATOR
Intervention: Single preoperative intra-vesical instillation of mitomycin C (pre-TURB instillation)
Number of subjects: 35
Study 32891506 — intervention group
Group type: EXPERIMENTAL
Intervention: Single immediate postoperative intra-vesical instillation of mitomycin C (post-TURB instillation)
Number of subjects: 35
Study 32891506 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pre-TURB and post-TURB instillation)
Number of subjects: 35
Study 36361203 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based multifaceted economic empowerment (EE) intervention
Number of subjects: 702
Study 36361203 — intervention group
Group type: COMPARATOR
Intervention: Control arm (not receiving EE)
Number of subjects: 702
Study 33546622 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 261
Study 33546622 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 261
Study 33424006 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning program (5 training sessions)
Number of subjects: 221
Study 35109492 — intervention group
Group type: EXPERIMENTAL
Intervention: DECENT programme
Number of subjects: 217
Study 35109492 — intervention group
Group type: COMPARATOR
Intervention: Printed educational materials (control)
Number of subjects: 217
Study 33248391 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention (Wave 1) starting in Year 1
Number of subjects: 67
Study 33248391 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (Wave 2) starting in Year 3
Number of subjects: 67
Study 36170789 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information
Number of subjects: 1200
Study 36170789 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information plus hypocrisy inducement
Number of subjects: 1200
Study 36170789 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1200
Study 33769679 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study 34543741 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG group (fluorescence imaging-guided lymphadenectomy)
Number of subjects: 514
Study 34543741 — intervention group
Group type: COMPARATOR
Intervention: non-ICG group (conventional lymphadenectomy)
Number of subjects: 514
Study 35495879 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor rehabilitation training based on routine nursing (experimental group)
Number of subjects: 70
Study 35495879 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (control group)
Number of subjects: 70
Study 35495879 — intervention group
Group type: EXPERIMENTAL
Intervention: Image enhancement algorithm processing
Number of subjects: 70
Study 35495879 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor rehabilitation training (both groups)
Number of subjects: 70
Study 32046753 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) applied once within 48 hours of menstruation at six abdominal myofascial trigger points.
Number of subjects: 36
Study 32046753 — intervention group
Group type: COMPARATOR
Intervention: Sham rESWT (placebo control) applied on the same sites but without energy input.
Number of subjects: 36
Study 32046753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups will be assessed for changes using the Zung Self-rating Anxiety Scale and Self-rating Depression Scale.
Number of subjects: 36
Study 32046753 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) changes in brain regions will be assessed.
Number of subjects: 36
Study 34348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IVAI) treat-and-extend (T&E)
Number of subjects: 50
Study 34348351 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept injection (IVAI) T&E plus sham photodynamic therapy (PDT)
Number of subjects: 50
Study 34348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IVAI) T&E plus standard fluence PDT with verteporfin
Number of subjects: 50
Study 34348351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IVAI) T&E
Number of subjects: 50
Study 34348351 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept injection (IVAI) T&E plus sham PDT
Number of subjects: 50
Study 33633278 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 × 150 mg caffeine daily)
Number of subjects: 20
Study 33633278 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal (3 × 150 mg caffeine for 8 days, then switch to placebo)
Number of subjects: 20
Study 33633278 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 × placebo daily)
Number of subjects: 20
Study 33633278 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine and Withdrawal conditions
Number of subjects: 20
Study 35499655 — intervention group
Group type: EXPERIMENTAL
Intervention: Helioseal F Plus
Number of subjects: 92
Study 35499655 — intervention group
Group type: COMPARATOR
Intervention: Helioseal F
Number of subjects: 92
Study 33907800 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietex ProGrip™ mesh-supported closure
Number of subjects: 200
Study 33907800 — intervention group
Group type: COMPARATOR
Intervention: Primary closure (control group)
Number of subjects: 200
Study 33201503 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 μM Cd
Number of subjects: 20
Study 33201503 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μM Cd
Number of subjects: 20
Study 33201503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cd stress
Number of subjects: 20
Study 33201503 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 M NaCl extraction
Number of subjects: 20
Study 33201503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cd concentrations
Number of subjects: 20
Study 33201503 — intervention group
Group type: EXPERIMENTAL
Intervention: Uronic acid, total sugar contents, PME activity
Number of subjects: 20
Study 32568470 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavit G
Number of subjects: 54
Study 32568470 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 54
Study 34171493 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training intervention (12 therapy sessions)
Number of subjects: 44
Study 34171493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study 33354964 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal grains and cereal products
Number of subjects: 56
Study 35590395 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular symptom monitoring with feedback using the Integrated Palliative Outcome Scale‐Renal (IPOS‐Renal) survey
Number of subjects: 2400
Study 35590395 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2400
Study 35590395 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular symptom monitoring with feedback
Number of subjects: 2400
Study 33624806 — intervention group
Group type: EXPERIMENTAL
Intervention: Elinzanetant 120 mg
Number of subjects: 33
Study 33624806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32455565 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LI) with a customized low glycemic index diet
Number of subjects: 0
Study 32455565 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC) involving generic counseling about healthy diet and physical activity
Number of subjects: 0
Study 35014030 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUE Dads program participants
Number of subjects: 1042
Study 33742316 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravesical trigonal-only injection of OnabotulinumtoxinA
Number of subjects: 45
Study 33742316 — intervention group
Group type: COMPARATOR
Intervention: 20 trigone-sparing injections of OnabotulinumtoxinA
Number of subjects: 45
Study 35822358 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Axial Roll Test (RART)
Number of subjects: 400
Study 35822358 — intervention group
Group type: COMPARATOR
Intervention: Traditional Roll Test (SRT)
Number of subjects: 400
Study 33710268 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world evidence studies on diabetes treatments
Number of subjects: 0
Study 33710268 — intervention group
Group type: COMPARATOR
Intervention: New-user active comparator cohort design
Number of subjects: 0
Study 33710268 — intervention group
Group type: EXPERIMENTAL
Intervention: Propensity score analyses
Number of subjects: 0
Study 32897130 — intervention group
Group type: EXPERIMENTAL
Intervention: Passport to Wellness (PtW) intervention with peer support
Number of subjects: 80
Study 32897130 — intervention group
Group type: COMPARATOR
Intervention: Comparison group lacking peer support
Number of subjects: 80
Study 33653674 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior rhabdosphincter reconstruction (PRR)
Number of subjects: 153
Study 33653674 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no PRR)
Number of subjects: 153
Study 33574323 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of COPD among residents who had heard of it (n = 49)
Number of subjects: 5420
Study 33574323 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses from residents who had never heard of COPD (n = 5371)
Number of subjects: 5420
Study 36122605 — intervention group
Group type: COMPARATOR
Intervention: Nystatin oral suspension (Control‐100,000IU/mL; 4 × /day)
Number of subjects: 40
Study 36122605 — intervention group
Group type: EXPERIMENTAL
Intervention: Trusoft relined without nystatin (Tru)
Number of subjects: 40
Study 36122605 — intervention group
Group type: EXPERIMENTAL
Intervention: Trusoft relined with nystatin (Ny)
Number of subjects: 40
Study 36122605 — intervention group
Group type: EXPERIMENTAL
Intervention: Trusoft relined with chlorhexidine diacetate (Chx)
Number of subjects: 40
Study 33398922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural social skills training (CBSST)
Number of subjects: 203
Study 33398922 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 203
Study 35619283 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 48
Study 35619283 — intervention group
Group type: COMPARATOR
Intervention: Incremental shuttle walk test (ISWT)
Number of subjects: 48
Study 35619283 — intervention group
Group type: COMPARATOR
Intervention: Sedentary patients
Number of subjects: 48
Study 35619283 — intervention group
Group type: COMPARATOR
Intervention: Higher NYHA functional class
Number of subjects: 48
Study 35619283 — intervention group
Group type: COMPARATOR
Intervention: ISWT
Number of subjects: 48
Study 34323130 — intervention group
Group type: EXPERIMENTAL
Intervention: Village Health Volunteer (VHV) program
Number of subjects: 344
Study 34323130 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 344
Study 35840893 — intervention group
Group type: EXPERIMENTAL
Intervention: Single cognitive training
Number of subjects: 150
Study 35840893 — intervention group
Group type: EXPERIMENTAL
Intervention: Single motor training
Number of subjects: 150
Study 35840893 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous cognitive-motor training
Number of subjects: 150
Study 33378447 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8% metronidazole gel
Number of subjects: 66
Study 33378447 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminder and placebo gel
Number of subjects: 66
Study 33378447 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 66
Study 34192721 — intervention group
Group type: EXPERIMENTAL
Intervention: Ottawa scale
Number of subjects: 50
Study 34192721 — intervention group
Group type: EXPERIMENTAL
Intervention: Chen scale
Number of subjects: 50
Study 34097053 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous rehydration
Number of subjects: 0
Study 34097053 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35666856 — intervention group
Group type: EXPERIMENTAL
Intervention: Goat Milk Based Infant Formula (GMF)
Number of subjects: 218
Study 35666856 — intervention group
Group type: COMPARATOR
Intervention: Cow Milk Formula (CMF)
Number of subjects: 218
Study 35666856 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast Fed (BF)
Number of subjects: 218
Study 34762534 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-Assisted Drug Delivery (LADD) with 10% tranexamic acid solution
Number of subjects: 10
Study 34762534 — intervention group
Group type: COMPARATOR
Intervention: Picosecond laser alone
Number of subjects: 10
Study 32818951 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist introduction into the ambulatory kidney care model
Number of subjects: 25016
Study 32818951 — intervention group
Group type: COMPARATOR
Intervention: Not prescribed a statin
Number of subjects: 25016
Study 32818951 — intervention group
Group type: COMPARATOR
Intervention: Potentially inappropriate prescriptions
Number of subjects: 25016
Study 32818951 — intervention group
Group type: COMPARATOR
Intervention: Rate of potentially inappropriate prescribing
Number of subjects: 25016
Study 35867960 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (BV-AVD)
Number of subjects: 170
Study 35867960 — intervention group
Group type: COMPARATOR
Intervention: Standard doxorubicin, bleomycin, vincristine, and dacarbazine (ABVD)
Number of subjects: 170
Study 35867960 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (BV-AVD) for patients with high total metabolic tumor volume
Number of subjects: 170
Study 35867960 — intervention group
Group type: COMPARATOR
Intervention: Standard doxorubicin, bleomycin, vincristine, and dacarbazine (ABVD) for patients with high total metabolic tumor volume
Number of subjects: 170
Study 35604680 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 1000
Study 35604680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 32422456 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS treatment
Number of subjects: 97
Study 32422456 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS treatment
Number of subjects: 97
Study 34921090 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular preventive medication
Number of subjects: 21
Study 32178668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine alone (1 mg/kg)
Number of subjects: 45
Study 32178668 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (control group)
Number of subjects: 45
Study 32178668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine combined with meloxicam (0.2 mg/kg)
Number of subjects: 45
Study 33128351 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease modifying therapy
Number of subjects: 30023
Study 33128351 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidemiological studies
Number of subjects: 30023
Study 33128351 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies on effectiveness of disease modifying treatments
Number of subjects: 30023
Study 32162530 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score system based on demographic and clinicopathological variables
Number of subjects: 827
Study 32162530 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score system
Number of subjects: 827
Study 33145695 — intervention group
Group type: EXPERIMENTAL
Intervention: History of pressured sex (often)
Number of subjects: 1490
Study 33145695 — intervention group
Group type: COMPARATOR
Intervention: History of verbal abuse
Number of subjects: 1490
Study 33145695 — intervention group
Group type: COMPARATOR
Intervention: History of physical abuse
Number of subjects: 1490
Study 33179978 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing larger body shapes
Number of subjects: 891
Study 33179978 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing varying body shapes
Number of subjects: 891
Study 32454259 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 0
Study 32454259 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 0
Study 32085923 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS) - 15 Gy in one fraction
Number of subjects: 22
Study 32085923 — intervention group
Group type: COMPARATOR
Intervention: Whole brain radiotherapy (WBRT) - 20 Gy in five fractions
Number of subjects: 22
Study 36343847 — intervention group
Group type: EXPERIMENTAL
Intervention: Linerixibat 180 mg once daily
Number of subjects: 147
Study 36343847 — intervention group
Group type: EXPERIMENTAL
Intervention: Linerixibat 40 mg twice daily
Number of subjects: 147
Study 36343847 — intervention group
Group type: EXPERIMENTAL
Intervention: Linerixibat 90 mg twice daily
Number of subjects: 147
Study 36343847 — intervention group
Group type: COMPARATOR
Intervention: Linerixibat (various doses)
Number of subjects: 147
Study 34638611 — intervention group
Group type: EXPERIMENTAL
Intervention: EV-RIPC
Number of subjects: 30
Study 34638611 — intervention group
Group type: COMPARATOR
Intervention: EV-naive
Number of subjects: 30
Study 34638611 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 30
Study 32040891 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music, covering the PFT screen, or doing breathing meditation before PFTs
Number of subjects: 75